JP2025506504A5 - - Google Patents
Info
- Publication number
- JP2025506504A5 JP2025506504A5 JP2024547671A JP2024547671A JP2025506504A5 JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5 JP 2024547671 A JP2024547671 A JP 2024547671A JP 2024547671 A JP2024547671 A JP 2024547671A JP 2025506504 A5 JP2025506504 A5 JP 2025506504A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- deuterium
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263268019P | 2022-02-15 | 2022-02-15 | |
| US202263268022P | 2022-02-15 | 2022-02-15 | |
| US63/268,019 | 2022-02-15 | ||
| US63/268,022 | 2022-02-15 | ||
| US202263386375P | 2022-12-07 | 2022-12-07 | |
| US63/386,375 | 2022-12-07 | ||
| PCT/EP2023/053744 WO2023156450A1 (en) | 2022-02-15 | 2023-02-15 | Therapeutic phenethylamine compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506504A JP2025506504A (ja) | 2025-03-11 |
| JP2025506504A5 true JP2025506504A5 (enExample) | 2026-02-20 |
Family
ID=85278498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547671A Pending JP2025506504A (ja) | 2022-02-15 | 2023-02-15 | 治療用フェネチルアミン組成物及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250236589A1 (enExample) |
| EP (1) | EP4479373A1 (enExample) |
| JP (1) | JP2025506504A (enExample) |
| KR (1) | KR20240153566A (enExample) |
| AU (1) | AU2023222397A1 (enExample) |
| CA (1) | CA3244275A1 (enExample) |
| WO (1) | WO2023156450A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023539113A (ja) | 2020-08-18 | 2023-09-13 | サイビン アイアールエル リミテッド | フェネチルアミン誘導体、組成物およびその使用方法 |
| WO2025228547A1 (en) * | 2024-05-01 | 2025-11-06 | Cybin Irl Limited | Processes for preparing phenethylamine compounds |
| WO2026030444A1 (en) * | 2024-07-30 | 2026-02-05 | Otsuka America Pharmaceutical, Inc | Compounds useful for the treatment of disorders and methods related thereto |
| CN120607467A (zh) * | 2025-06-12 | 2025-09-09 | 延安大学 | 烷基磺酰类一氟甲硒基化试剂及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| US6488648B1 (en) | 1999-01-14 | 2002-12-03 | Teijin Limited | Device for feeding a powder in a predetermined amount and method thereof |
| NZ514442A (en) | 1999-03-03 | 2003-08-29 | Optinose As | Nasal delivery device |
| GB0114272D0 (en) | 2001-06-12 | 2001-08-01 | Optinose As | Nasal delivery device |
| GB0121568D0 (en) | 2001-09-06 | 2001-10-24 | Optinose As | Nasal delivery device |
| GB0019715D0 (en) | 2000-08-10 | 2000-09-27 | Pa Consulting Services | Device for delivering physiologically active agent in powdered form |
| ZA200306564B (en) | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
| AU2002340083A1 (en) | 2001-09-28 | 2003-04-07 | Kurve Technology, Inc | Nasal nebulizer |
| GB0207422D0 (en) | 2002-03-28 | 2002-05-08 | Optinose As | Nasal devices |
| GB0207817D0 (en) | 2002-04-04 | 2002-05-15 | Optinose As | Nasal devices |
| GB0209494D0 (en) | 2002-04-25 | 2002-06-05 | Optinose As | Nasal devices |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
-
2023
- 2023-02-15 US US18/730,397 patent/US20250236589A1/en active Pending
- 2023-02-15 CA CA3244275A patent/CA3244275A1/en active Pending
- 2023-02-15 KR KR1020247028837A patent/KR20240153566A/ko active Pending
- 2023-02-15 WO PCT/EP2023/053744 patent/WO2023156450A1/en not_active Ceased
- 2023-02-15 EP EP23705529.8A patent/EP4479373A1/en active Pending
- 2023-02-15 JP JP2024547671A patent/JP2025506504A/ja active Pending
- 2023-02-15 AU AU2023222397A patent/AU2023222397A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540017A5 (enExample) | ||
| JP2023539113A5 (enExample) | ||
| JP2025505745A5 (enExample) | ||
| JP2023526856A5 (enExample) | ||
| JP2021523200A5 (enExample) | ||
| JP2024529839A5 (enExample) | ||
| JP2024520481A5 (enExample) | ||
| JP2025509697A5 (enExample) | ||
| JP2013010792A5 (enExample) | ||
| JP2009531277A5 (enExample) | ||
| JP2024522065A5 (enExample) | ||
| JP2023531709A5 (enExample) | ||
| JP2021528427A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| JP2004511556A5 (enExample) | ||
| JP2012523440A5 (enExample) | ||
| AR066904A1 (es) | Pirrolopiridinas y pirazolopiridinas sustituidas como moduladores de las quinasas, una composicion farmaceutica que las incluye y su uso en el tratamiento del cancer | |
| JP2012521994A5 (enExample) | ||
| JP2007508360A5 (enExample) | ||
| JP2023533203A5 (enExample) | ||
| JP2020063289A5 (enExample) | ||
| JP2023540733A5 (enExample) | ||
| JP2025111616A5 (enExample) | ||
| JP2017531016A5 (enExample) | ||
| JP2023518044A5 (enExample) |